The significance of new onset atrial fibrillation complicating acute myocardial infarction

Clinical Research in Cardiology

Volumn 101, Issue 1, 2012, Pages 17-22

  Zusman, Oren ^a   Amit, Guy ^a   Gilutz, Harel ^a   Zahger, Doron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anticoagulation; Atrial fibrillation; Myocardial infarction; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; FLECAINIDE; PROPAFENONE; SOTALOL; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTOLIC DYSFUNCTION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; STROKE; SURVIVAL RATE;

EID: 84856267004     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0357-5     Document Type: Article

References (18)

1. Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong W, Granger CB (2009) Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J 30:2019-2028
2. B Crenshaw C Granger A Stebbins E Topol R Califf 1997 Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries J Am Coll Cardiol 30 2 406 413 9247512 10.1016/S0735-1097(97)00194-0 1:STN:280: DyaK2szptVKmtw%3D%3D (Pubitemid 27339320)
3. F Pizzetti FM Turazza MG Franzosi S Barlera A Ledda AP Maggioni L Santoro G Tognoni GISSI-3 Investigators 2001 Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data Heart 86 5 527 532 11602545 10.1136/heart.86.5.527 1:STN:280:DC%2BD3MrlsFOksw%3D%3D (Pubitemid 32999863)
4. CK Wong HD White RG Wilcox DA Criger RM Califf EJ Topol EM Ohman 2000 New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience Am Heart J 140 6 878 885 11099991 10.1067/mhj.2000.111108 1:STN:280:DC%2BD3M%2Fnt1ajug%3D%3D
5. RJ Goldberg J Yarzebski D Lessard J Wu JM Gore 2002 Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective Am Heart J 143 3 519 527 11868060 10.1067/mhj.2002.120410 (Pubitemid 34185185)
6. M Lehto S Snapinn K Dickstein K Swedberg MS Nieminen OPTIMAAL Investigators 2005 Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience Eur Heart J 26 4 350 356 15618041 10.1093/eurheartj/ehi064 (Pubitemid 40287380)
7. C-K Wong HD White RG Wilcox DA Criger RM Califf EJ Topol EM Ohman 2003 Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial Card Electrophysiol Rev 7 3 201 207 14739713 10.1023/B:CEPR.0000012382.81986.47 (Pubitemid 38256100)
8. P Jabre VL Roger MH Murad AM Chamberlain 2011 Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis Circulation 123 1587 1593 21464054 10.1161/CIRCULATIONAHA.110. 986661
9. C-W Siu M-H Jim H-H Ho R Miu SWL Lee C-P Lau H-F Tse 2007 Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke Chest 132 1 44 49 17400657 10.1378/chest.06-2733 (Pubitemid 47071765)
10. AJ Camm P Kirchhof GYH Lip U Schotten I Savelieva S Ernst ICV Gelder N Al-Attar G Hindricks B Prendergast H Heidbuchel O Alfieri A Angelini D Atar P Colonna RD Caterina JD Sutter A Goette B Gorenek M Heldal SH Hohloser P Kolh J-YL Heuzey P Ponikowski FH Rutten 2010 Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2369 2429 20802247 10.1093/eurheartj/ehq278
11. U Stenestrand J Lindback L Wallentin RIKS-HIA Registry 2005 Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA) Circulation 112 21 3225 3231 16301355 10.1161/CIRCULATIONAHA.105.552984 1:CAS:528:DC%2BD2MXht1arsrnI (Pubitemid 43739366)
12. OD Pedersen H Bagger L Kober C Torp-Pedersen 1999 Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 4 376 380 10421597 1:CAS:528:DyaK1MXltFOltLs%3D (Pubitemid 29362407)
13. L Køber PEB Thomsen M Møller C Torp-Pedersen J Carlsen E Sandøe K Egstrup E Agner J Videbaek B Marchant AJ Camm 2000 Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial Lancet 356 9247 2052 2058 11145491 10.1016/S0140-6736(00)03402-4 (Pubitemid 32009820)
14. T Becker T Kleemann M Strauss K Doenges S Schneider J Senges K Seidl 2008 Long-term prognosis after cardioversion of the first episode of symptomatic atrial fibrillation: a condition believed to be benign revised Clin Res Cardiol 97 2 74 82 17938851 10.1007/s00392-007-0584-y (Pubitemid 351257990)
15. S Connolly J Pogue R Hart M Pfeffer S Hohnloser S Chrolavicius S Yusuf 2006 Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 9526 1903 1912 16765759 10.1016/S0140-6736(06)68845-4 1:CAS:528: DC%2BD28XlsFCrsLg%3D (Pubitemid 43842067)
16. M Eldar M Canetti Z Rotstein V Boyko S Gottlieb E Kaplinsky S Behar SPRINT and Thrombolytic Survey Groups 1998 Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era Circulation 97 10 965 970 9529264 1:STN:280:DyaK1c7ovVWisQ%3D%3D (Pubitemid 28125468)
17. P Kirchhof A Auricchio J Bax H Crijns J Camm HC Diener A Goette G Hindricks S Hohnloser L Kappenberger 2007 Outcome parameters for trials in atrial fibrillation: executive summary Eur Heart J 28 22 2803 17897924 10.1093/eurheartj/ehm358 (Pubitemid 350135529)
18. RD Lopes A Starr CF Pieper SM Al-Khatib LK Newby RH Mehta FV de Werf KW Mahaffey PW Armstrong RA Harrington HD White L Wallentin CB Granger 2010 Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes Am J Med 123 2 134 140 20103022 10.1016/j.amjmed.2009. 09.015 1:CAS:528:DC%2BC3cXpsleltA%3D%3D